Michael P. Johnson - Feb 13, 2025 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Executive Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Michael P. Johnson
Stock symbol
IDXX
Transactions as of
Feb 13, 2025
Transactions value $
-$52,455
Form type
4
Date filed
2/18/2025, 09:43 PM
Previous filing
Feb 16, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +176 +76.41% $0.00 406 Feb 14, 2025 Direct F1
transaction IDXX Common Stock Options Exercise $0 +179 +44.05% $0.00 585 Feb 14, 2025 Direct
transaction IDXX Common Stock Tax liability -$52.5K -118 -20.16% $444.53 467 Feb 14, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award $0 +3.66K $0.00 3.66K Feb 13, 2025 Common Stock 3.66K $459.76 Direct F2
transaction IDXX Incentive Stock Option (right-to-buy) Award $0 +217 $0.00 217 Feb 13, 2025 Common Stock 217 $459.76 Direct F3
transaction IDXX Restricted Stock Unit Award $0 +870 $0.00 870 Feb 13, 2025 Common Stock 870 Direct F4
transaction IDXX Restricted Stock Unit Options Exercise $0 -176 -33.33% $0.00 352 Feb 14, 2025 Common Stock 176 Direct F5
transaction IDXX Restricted Stock Unit Options Exercise $0 -179 -25.07% $0.00 535 Feb 14, 2025 Common Stock 179 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 47 shares purchased under the Issuer Employee Stock Purchase Plan on March 29, 2024, June 28, 2024, September 31, 2024 and December 31, 2024.
F2 Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2026.
F3 Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2029.
F4 Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2026.
F5 Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024.
F6 Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning on February 14, 2025.